Egeland EV, Seip K, Skourti E, Oy GF, et al. The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy. Br J Cancer 2024 Oct 10. doi: 10.1038/s41416-024-02875.
PMID: 39390250